Exponent Inc (EXPO)

Exponent, Inc. is a science and engineering consulting company listed on NASDAQ under the ticker EXPO. The business operates in the United States and internationally and is organized into two reporting segments: Engineering and Other Scientific, and Environmental and Health. Its work spans a broad range of technical fields, including biomechanics, biomedical engineering, civil and structural engineering, construction consulting, data science, electrical engineering and computer science, human factors, materials and corrosion, mechanical engineering, metallurgical and corrosion engineering, polymer and chemistry, thermal sciences, and vehicle engineering. Exponent also provides services related to chemical regulation, food safety, ecology, environmental science, and health sciences, along with product safety, litigation support, and other technical and regulatory work. Its clients include companies and organizations in sectors such as chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, industrial equipment, and transportation.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-EXPO
$73.61
20.1% Upside
Undervalued
$81.67
33.2% Upside
Undervalued
Good
1.24
2.0%
July 30, 2026
27.3x
8.8x
5.4x
3.041 B
2.938 B
2.6%
98.8%
8.4
56.7%
104.1%
Valuation • Fair Value

Exponent Inc (NASDAQ-EXPO) Fair Value by Valuation Model

Compare the primary fair value estimate for Exponent Inc (NASDAQ-EXPO) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$73.61

Estimated upside of 20.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$72.87

Discounted cash flow valuation reference.

Ben Graham Formula Value

$24.91

Classic Ben Graham valuation formula reference.

DDM Fair Value

$70.10

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$75.51

Comparable-company valuation reference.

Analyst Price Target

$81.67

Analysts imply upside of 33.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Exponent Inc (NASDAQ-EXPO) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Exponent Inc (NASDAQ-EXPO)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

551.1 M

Current operating scale indicator.

Revenue Forecast

585.4 M

Forward revenue estimate.

EBITDA

126.8 M

Current operating profitability reference.

EBITDA Forecast

163.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Exponent Inc (NASDAQ-EXPO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Exponent Inc (NASDAQ-EXPO)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.34

No elevated caution signal from this screen.

Altman Z-Score

8.4

Relatively strong balance-sheet zone.

FCF / Net Income

104.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Exponent Inc (NASDAQ-EXPO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Exponent Inc (NASDAQ-EXPO)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 30, 2026

Days to Earnings

9

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.0%

Income yield reference.

Upcoming Dividend

1.24

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

56.7%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Exponent Inc (NASDAQ-EXPO), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Exponent Inc (NASDAQ-EXPO) Stock Forecast & Technical Outlook

Review Exponent Inc (NASDAQ-EXPO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Exponent Inc (NASDAQ-EXPO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Exponent Inc (NASDAQ-EXPO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Exponent Inc (NASDAQ-EXPO) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Exponent Inc (NASDAQ-EXPO) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Exponent Inc (NASDAQ-EXPO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Exponent Inc (NASDAQ-EXPO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Exponent Inc (NASDAQ-EXPO) has a Buy consensus, with 2 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 1
Sell 0
FAQ Fast Investor Answers

Exponent Inc (NASDAQ-EXPO) Stock FAQ

Quick answers about Exponent Inc (NASDAQ-EXPO) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$73.61
Estimated upside 20.1%
Valuation Rating
Undervalued
Estimated upside of 20.1%
Analyst Target
$81.67
Implied upside 33.2%
Financial Health
Good
Current financial-health read

The current fair value estimate for Exponent Inc (NASDAQ-EXPO) is $73.61. This implies an estimated upside of 20.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 20.1% versus the current market price.

The available analyst price target for Exponent Inc (NASDAQ-EXPO) is $81.67. The analyst target implies estimated upside of 33.2%.

The current financial health read for Exponent Inc (NASDAQ-EXPO) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Exponent Inc (NASDAQ-EXPO) is July 30, 2026.

Based on the current data, dividend yield is 2.0%, upcoming dividend amount is 1.24.

The current P/E ratio listed for Exponent Inc (NASDAQ-EXPO) is 27.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Exponent Inc is 3.041 B.

The current enterprise value listed for Exponent Inc is 2.938 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Exponent Inc is NASDAQ-EXPO, and the stock is listed on NASDAQ.

Exponent Inc (NASDAQ-EXPO) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Exponent Inc is 2.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Exponent Inc is 98.8%. Free float helps investors understand how much of the share base is available for public trading.